AXIM® Biotechnologies to Develop Chewing Gum with Bioequivalence to Marinol®

by adminTorusBrand | Mar 30, 2017 | Axim Biotechnologies, Company News, Scientific Research

[vc_row][vc_column][vc_column_text] AXIM® Biotechnologies, a major Medical Marijuana, Inc. investment company, has taken the first steps toward developing a chewing gum bioequivalent to Marinol, made using a synthetic version of THC or tetrahydrocannabinol. This week,...

AXIM Biotechnologies Partners with Ora, Inc. for Cannabinoid-Based Drug Development and Clinical Trials for Eye Conditions

by adminTorusBrand | Mar 23, 2017 | Axim Biotechnologies, Press Releases, Scientific Research

In order to fast-track approval of its new products, AXIM® Biotechnologies, Inc., a Medical Marijuana, Inc. investment company, has retained the services of Ora®, Inc. for the development of its cannabinoid-based eye treatments.   A global Contract Research...

Noted Neurologist Holds News Conference in Mexico to Reveal Study Linking RSHO-X™ to Improvements in Seizure Frequency

by adminTorusBrand | Mar 17, 2017 | Company News, HempMeds Mexico, Scientific Research

[vc_row][vc_column][vc_column_text]A press conference held this past Tuesday in Mexico announced the positive results of a groundbreaking epilepsy study on the effects of CBD on seizures. Conducted by renowned pediatric neurologist Dr. Saul Garza Morales, the study...

RSHO-X™ at Center of New Epilepsy Study Revealing Significant Reduction of Seizures

by adminTorusBrand | Mar 14, 2017 | Company News, HempMeds Mexico, Scientific Research

[vc_row][vc_column][vc_column_text]The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not...

Study Results: Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces Release of Study using its Real Scientific Hemp Oil-X™ to Treat Epileptic Children

by adminTorusBrand | Mar 14, 2017 | HempMeds Mexico, Press Releases, Scientific Research

The following information is presented for educational purposes only. Medical Marijuana Inc. provides this information to provide an understanding of the potential applications of cannabidiol. Links to third party websites do not constitute an endorsement of these...

Dope Magazine Features Medical Marijuana, Inc. Subsidiary HempMeds® Mexico In Historic ‘Look At America’s Reverse-Cannabis Pipeline’

by adminTorusBrand | Mar 8, 2017 | HempMeds Mexico, Press Releases, Scientific Research

Article Also Details Company’s Pioneering Role in Latin America’s Burgeoning Cannabis Market SAN DIEGO, March 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary HempMeds® Mexico, the first company to receive government...